Meningitis B: HSE Reassures Public Amidst UK Outbreak

The Health Service Executive (HSE) in Ireland has issued a statement reassuring the public that there is currently no evidence of an increase in invasive meningococcal disease, including meningitis, beyond expected seasonal levels. This comes as health authorities in the UK continue to investigate a serious outbreak of meningococcal disease in Kent, where two young adults have tragically died.

UK Outbreak and Irish Monitoring

As of March 19, 2026, the outbreak in Kent, UK, comprises 15 confirmed laboratory cases and 12 notifications still under investigation, totaling 27 cases. All confirmed cases to date involve young adults, with six identified as group B meningococcal disease. The UK Health Security Agency (UKHSA) advises that the situation is evolving and further cases are possible. MSN

The HSE is maintaining regular contact with the UKHSA to monitor the situation closely. Dr. John Cuddihy, HSE National Director for Public Health, emphasized, “There is no evidence of an increase in invasive meningococcal disease activity in Ireland beyond expected seasonal and background levels. There is also currently no indication of links between any cases in Ireland and the outbreak reported in Kent.” RTÉ, CorkBeo, BreakingNews.ie

Meningococcal Disease in Ireland: Current Status

To date in 2026, Ireland has reported 12 cases of meningococcal disease, with no fatalities. Nine of these cases are Serogroup B. Last year, 60 cases of meningococcal disease were reported in Ireland, including 38 Serogroup B cases. CorkBeo

Recognizing the Symptoms

Meningococcal disease is a bacterial infection that can lead to meningitis and bloodstream infections. It’s crucial to be aware of the symptoms, which include:

• Fever
• Severe headache
• Vomiting
• Rapid breathing
• Cold hands and feet
• Drowsiness
• A rash that doesn’t fade under pressure

Dr. Cuddihy advises, “Do not wait for a rash. If someone is ill and getting worse, get medical help immediately.” BreakingNews.ie

Vaccination and Prevention

Several serotypes of the bacteria cause meningococcal disease, and vaccines are available for types A, B, C, W, and Y. The HSE provides vaccinations for babies and first-year secondary school students.

Dr. Lucy Jessop, Director of the HSE’s National Immunisation Office, explained that the MenB vaccine is included in the free national childhood immunisation schedule for babies born on or after October 1, 2016, administered in three doses at 2, 4, and 12 months. There is currently no catch-up program for older children. The MenACWY vaccine is offered in the first year of secondary school, protecting against strains A, C, W, and Y. BreakingNews.ie

Parents are encouraged to return consent forms for the MenACWY vaccine sent home with their children in school to ensure their children are protected.